John H Johnson Insider Trading $HSGX Ocugen, Inc.
Get free email notifications about insider trading for John H Johnson.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of John H Johnson. John H Johnson is CEO in IMCLONE SYSTEMS INC ($IMCLE) and Director in PORTOLA PHARMACEUTICALS INC ($PTLA) and Director in AVEO PHARMACEUTICALS INC ($AVEO) and Director in Sucampo Pharmaceuticals, Inc. ($SCMP) and Director in HISTOGENICS CORP ($HSGX) and Chief Executive Officer in MELINTA THERAPEUTICS, INC. /NEW/ ($MLNT) and Director in CEMPRA, INC. ($CEMP) and Interim CEO in MELINTA THERAPEUTICS, INC. /NEW/ ($MLNT) and Director in Verastem, Inc. ($VSTM) and Chief Executive Officer in Strongbridge Biopharma plc ($SBBP) and Director in Strongbridge Biopharma plc ($SBBP) and Executive Chairman in Strongbridge Biopharma plc ($SBBP).
John H Johnson in Ocugen, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of John H Johnson: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 19 2018
$HSGX Market Capitalization: $28.25M
$HSGX Previous Close: $1.66
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of John H Johnson in Ocugen, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AVEO, IMCLE, MLNT, HSGX, PTLA, SBBP, SCMP, VSTM
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 19 2018 | HSGX | HISTOGENICS CORP | JOHNSON JOHN | Director | Option Exercise | A | 2.97 | 25,000 | 74,250 | 25,000 | |
| Jun 14 2017 | HSGX | HISTOGENICS CORP | JOHNSON JOHN | Director | Option Exercise | A | 1.70 | 25,000 | 42,500 | 25,000 | |
| Dec 19 2016 | HSGX | HISTOGENICS CORP | JOHNSON JOHN | Director | Option Exercise | A | 1.58 | 10,000 | 15,800 | 10,000 | |
| Jun 26 2015 | HSGX | HISTOGENICS CORP | JOHNSON JOHN | Director | Option Exercise | A | 6.86 | 10,475 | 71,859 | 10,475 |
Page: 1